InnovaHealth Partners

InnovaHealth Partners is a medical private equity firm based in New York, established in 2016. The firm specializes in growth buyouts and late-stage investments, focusing primarily on medical technology companies, particularly those involved in medical devices and disruptive technologies. InnovaHealth Partners aims to acquire controlling positions as a lead investor, with a preference for companies located in the United States, Europe, and Israel. As a Registered Investment Adviser, the firm is dedicated to fostering innovation in the healthcare sector through strategic investments.

Toby Cosgrove

Senior Partner

Ross Julian

Associate Director

John C. McCormick

Managing Director

5 past transactions

Materna Medical

Series B in 2022
Materna Medical, Inc. is a medical device company based in Mountain View, California, specializing in products aimed at enhancing women's pelvic health and reducing childbirth-related injuries. Established in 2010, the company launched Milli in 2018, the first expanding vaginal dilator designed to alleviate pelvic pain, a condition affecting over 20 million women. Materna Medical is also conducting a clinical trial for Materna Prep, a device intended to be used during the first stage of labor to expedite delivery and minimize internal damage to the pelvic region. The innovative features of Materna's devices not only provide significant health benefits to patients but also aim to save physicians' time, shorten delivery durations, and reduce overall healthcare costs by decreasing the incidence of pelvic injuries.

Radiaction

Venture Round in 2022
Radiaction is focused on revolutionizing radiation safety for medical personnel involved in fluoroscopy-guided procedures, particularly in interventional cardiology and electrophysiology. The company has developed an innovative radiation shielding system that effectively transfers radiation exposure from personnel to the fluoroscopy equipment, while simultaneously blocking scattered radiation at its source. This technology significantly enhances the level of protection for medical teams compared to traditional lead aprons and shields, thereby improving comfort and safety during procedures. By eliminating the need for cumbersome protective apparel and manually operated shields, Radiaction aims to increase the capacity and productivity of medical teams within interventional suites.

Route 92

Series E in 2021
Route 92 Medical, Inc. specializes in developing innovative medical devices aimed at treating acute ischemic stroke and related conditions. The company has created a stealthy catheter, a rapid aspiration thrombectomy system, and an intra-cerebral implant delivery system. These products are designed to assist healthcare professionals in effectively treating strokes and enhancing patient recovery. Founded in 2015 and based in San Mateo, California, Route 92 Medical continues to focus on advancing technologies that improve outcomes for stroke patients.

Radiaction

Series B in 2020
Radiaction is focused on revolutionizing radiation safety for medical personnel involved in fluoroscopy-guided procedures, particularly in interventional cardiology and electrophysiology. The company has developed an innovative radiation shielding system that effectively transfers radiation exposure from personnel to the fluoroscopy equipment, while simultaneously blocking scattered radiation at its source. This technology significantly enhances the level of protection for medical teams compared to traditional lead aprons and shields, thereby improving comfort and safety during procedures. By eliminating the need for cumbersome protective apparel and manually operated shields, Radiaction aims to increase the capacity and productivity of medical teams within interventional suites.

Koelis

Acquisition in 2019
Koelis SAS, founded in 2006 and headquartered in Meylan, France, specializes in the development of medical imaging products aimed at enhancing urological interventions. The company offers a range of innovative solutions, including the Trinity fusion biopsy system and the Steady Pro holder, which assist physicians in performing biopsies and treatments. Its software platforms, such as MrDraw, PROMAP US, PROMAP MR, and PROMAP 2L, facilitate planning and reviewing fusion biopsies, as well as providing advanced 3D mapping and image fusion capabilities. Additionally, Koelis provides Urostation, a mobile software platform that integrates 3D ultrasound and organ-based tracking. These technologies are designed to improve diagnostic precision and increase cancer detection rates for urologists and radiologists, thereby enhancing prostate cancer management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.